TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: voluntary maximum force reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Theoretical Framework for Acceptability (TFA) questionnaire score
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Rate of engagement with video visits
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: hemorrhagic stroke incidence
Endpoint domain: Mortality/survival
Primary endpoint: Overactive bladder symptom score
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Stand and go
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in the inventory wellbeing score
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Number of Implant failure
Endpoint domain: Adverse events/effects
Primary endpoint: Number of patients needing revision surgery
Endpoint domain: Adverse events/effects
Primary endpoint: Rate of intraoperative tumor cell dissemination
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: ADL questionnaire score
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Fear average score
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Pain average score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Parents' Satisfaction Level
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Rate of access site or access-related vascular complications
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Number of omitted information
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Compliance with polyphenol supplementation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Satisfaction of the participants and their point of view on the experience
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change in hemodynamics
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Changes in Echocardiogram (ECHO)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Change in serum potassium value
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Consent rate of eligible
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Prevalence of childbirth Posttraumatic Stress Disorder (PTSD)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Prevalence of childbirth Posttraumatic Stress Symptoms (PTSS)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Number of Participants Who Underwent TURBT or Cystectomy as Scheduled
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: patient's functional status
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: clinically meaningful pain reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Within three months readmission
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Amplitude of LPP
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from baseline functional skills at 8 weeks
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Change from baseline TLR integration at 9 weeks
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: dHb contrast investigation via MR imaging
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: DNN model accuracy in detecting abnormal stroke gait patterns
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Protocol fidelity
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Cerebral vasospasms
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Participation in AUD Treatment on Day 30
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Number of patients reaching LDL-C target level
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Local failure free survival
Endpoint domain: Mortality/survival
Primary endpoint: CLEFT-Q change scores
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Intraclass Correlation Coefficient (ICC) of apnea-hypopnea index
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Time of maximum observed blood concentration (Tmax)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area under the concentration-time curve within a dosing interval (AUC(TAU))
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: percent of Glycated Hemoglobin (HbA1c)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: millimeter of mercury of systolic blood pressure (SBP)/diastolic blood pressure (DBP)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Health-Related Fitness
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Fertility Awareness
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Dental hypersensitivity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Helicobacter pylori clearance rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: viability
Endpoint domain: Physiological/clinical
Endpoint subdomain: Pregnancy and childbirth outcomes
Primary endpoint: continuation of pregnancy till 13 weeks
Endpoint domain: Physiological/clinical
Endpoint subdomain: Pregnancy and childbirth outcomes
Primary endpoint: Clinical signs of infection (body temperature > 38°C)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Change in Strengths and Difficulties Questionnaire (SDQ)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change in Bayley-4 Bayley Scales Test for Infant and Toddler Development
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Family Assessment Device - General Function Scale (FAD-GF)
Endpoint domain: Life impact
Endpoint subdomain: Family functioning
Primary endpoint: Incidence of Ipsilateral tubal patency
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: Change in Dual-task cost
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Static balance task
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Participants' engagement with the SHAPES app
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Feasibility of whole-body MRI for cancer surveillance
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Mucosal inflammation prediction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in the force generated by the muscle cell and/or muscle slice
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in the velocity of shortening by the muscle cell and/or muscle slice
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in the end-systolic force-length relationship of the muscle cell and/or muscle slice
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Relative frequency of patients with a germline mutation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Genetic outcomes
Primary endpoint: Proportion of leads with lowest failure rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Recurrence rate of bile duct stones
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Change of serum AMH level
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Change of ovarian antral follicle count (AFC)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: Presence of lung complications
Endpoint domain: Adverse events/effects
Primary endpoint: Changes in Behavioral Rating Scale (ABC) scores
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Efficacy assessment through NEI total score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in complete blood count
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Changes in comprehensive metabolic panel
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Changes in Donor Specific Antibodies
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Changes in urinalysis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Changes in Visual Acuity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Surgical margin positivity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Time to lesion resolution
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean rate of change in eGFR
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Center of pressure speed displacement in the anteroposterior direction with open eyes after intervention
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Center of pressure speed displacement in the latero-lateral direction with open eyes after intervention
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Center of pressure area with closed eyes after intervention
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Ischemic heart disease and/or stroke
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Micro/macro-albuminuria
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: LDL>2.5 mmol/L
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Langerhans cell density in the corneal epithelium
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Percentage of subjects who achieved clinical remission per adapted Mayo score at Week 8
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of Adverse Events (AEs) and Adverse Events of Special Interest (AESIs)
Endpoint domain: Adverse events/effects
Primary endpoint: Change from baseline in MMSE
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Change from baseline in ALFF
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Number of adverse device effects
Endpoint domain: Adverse events/effects
Primary endpoint: Number of suspected acute adverse reactions to the treatment
Endpoint domain: Adverse events/effects
Primary endpoint: Proportion of subjects maintaining biochemical response in IGF-1
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Biofilm quantification
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Burden of adverse events attributable to corticosteroid therapy
Endpoint domain: Adverse events/effects
Primary endpoint: Frequency and Duration of Use of Office Discipline Referrals, In-School Suspension, and Out-of-School Suspension
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Engagement vs. Disaffection with Learning Student-report
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Opioid and Other Substance Misuse
Endpoint domain: Adverse events/effects
Primary endpoint: cognitive functions improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in high sensitivity C-reactive protein (hsCRP)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Change in MOCA total scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Baseline Dyspnea Index/Transitional Dyspnea Index
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Self-Efficacy Perception
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Positive ACh test response
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: IBS-SSS (Irritable Bowel Syndrome Severity Scoring System)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Nutrient factor weights
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Radiographic bucco-lingual ridge width loss
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Technical success of RFA of GISTs lesions and metastasis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Change in Emotional Exhaustion
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change in Depersonalization
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change in personal accomplishment
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Bowel movement assessment
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Feasibility and acceptability - Screening
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Feasibility and acceptability - Recruitment
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Intervention Adherence
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Participant outcome completion
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Number of firearms stored locked
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Parent Engagement in Harm Reduction Firearm Storage Behaviors Score
Endpoint domain: Life impact
Endpoint subdomain: Personal circumstances
Primary endpoint: Management of twin pregnancy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Pregnancy and childbirth outcomes
Primary endpoint: Change of maximal oxygen consumption post-surgery
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change of anaerobic threshold post surgery
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change of six minute walking test result post-surgery
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: self-assessment of eczema severity
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: quantification of skin microbiota bacteria
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Amyotrophic Lateral Sclerosis Functional Rating Scale-Revised (ALSFRS-R)
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Choice stepping reaction time test (CSRTT)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Parenting stress
Endpoint domain: Life impact
Endpoint subdomain: Personal circumstances
Primary endpoint: Force perception via force matching tasks
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Position perception via position matching tasks
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Touch perception using Semmes Weinstein monofilament testing
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Fine motor control as assessed by visuomotor tracking performance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: GBT021601 Concentration in Whole Blood and Plasma at Predose
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Maximum Observed Concentration (Cmax) of GBT021601 in Whole Blood and Plasma
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area Under the Plasma Concentration-Time Curve From Time Zero to Infinity (AUC0-inf) of GBT021601 in Whole Blood and Plasma
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Vertical distance difference between scapula and T2
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Premenstrual Syndrome (PMS) Symptom Severity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Three-dimensional deviations
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: TpeakTend Interval
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Change in tissue characteristics
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in joint ROM
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in grip and pinch force
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Re-attendance
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Change in Dizziness Handicap Inventory
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Head Impulse Test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Relative change in serum d-dimer levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Incidence of subjects with Dose-limiting toxicities (DLT)
Endpoint domain: Adverse events/effects
Primary endpoint: Incidence of subjects with adverse events (AEs) and/or serious adverse events (SAEs)
Endpoint domain: Adverse events/effects
Primary endpoint: Maximum Observed Serum Concentration of AZD0486 (Cmax)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Daily Perseverative Thinking Questionnaire
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Changes in levels of physical activity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in functioning and health
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: respiratory infection risk
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Differences in sleep EEG power and/or stage changes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Percentage of Participants Who Achieve ≥ 1 Stage Improvement in Liver Fibrosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of study participants experiencing serious adverse events (SAEs)
Endpoint domain: Adverse events/effects
Primary endpoint: Severity of serious adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Duration of serious adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Number of participants enrolled with a social contact that agrees to participate
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Learning self-efficacy
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Motivated Strategies for Learning
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Learning test performance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Sedation status at separation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: General satisfaction with multidisciplinary care
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Serve velocity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Serve precision
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Serve bidimensional movement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: change from baseline to time of Masster thickness
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: change from baseline to time of tongue muscles thickness
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: change from baseline to time of swallowing muscle strength
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Change from Baseline constipation at 2 weeks using the Bristol Stool Form Scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Change from Baseline constipation at 2 weeks using the Constipation Assessment Scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Change from Baseline constipation at 2 weeks using the Visual Scale Analog for constipation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Change from Baseline constipation at 2 weeks using the Patient Assessment of Constipation Symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Body Aesthetic Clinical Evaluation (TRACE)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Accuracy of the system
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Acceptability of the sensor
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status